|
SHQ1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
2.91730000157031E-08 |
| Normal-vs-Stage3 |
3.10862446895044E-15 |
| Normal-vs-Stage4 |
1.62447832963153E-12 |
| Stage1-vs-Stage2 |
4.280600E-01 |
| Stage1-vs-Stage3 |
6.777700E-02 |
| Stage1-vs-Stage4 |
3.256300E-03 |
| Stage2-vs-Stage3 |
6.683800E-02 |
| Stage2-vs-Stage4 |
2.958100E-03 |
| Stage3-vs-Stage4 |
1.507970E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.11022302462516E-16 |
| Normal-vs-AfricanAmerican |
6.7973999984261E-08 |
| Normal-vs-Asian |
2.10530481936644E-11 |
| Caucasian-vs-AfricanAmerican |
9.867200E-01 |
| Caucasian-vs-Asian |
7.410200E-01 |
| AfricanAmerican-vs-Asian |
8.343600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.55111512312578E-16 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
2.675200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62714286489063E-12 |
| Normal-vs-Age(41-60Yrs) |
4.44089209850063E-16 |
| Normal-vs-Age(61-80Yrs) |
1.62725388719309E-12 |
| Normal-vs-Age(81-100Yrs) |
1.603990E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.815000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.551800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.294400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.659800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.359800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.921600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.035400E-03 |
| Classical-VS-Follicular |
9.553200E-01 |
| Classical-VS-Other |
2.064600E-01 |
| Classical-VS-Normal |
1.62447832963153E-12 |
| Tall-VS-Follicular |
1.967720E-02 |
| Tall-VS-Other |
9.025800E-01 |
| Tall-VS-Normal |
3.55204754498573E-12 |
| Follicular-VS-Other |
2.563200E-01 |
| Follicular-VS-Normal |
5.60309576513873E-11 |
| Other-VS-Normal |
7.59310000000291E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.99680288865056E-15 |
| Normal-vs-N1 |
1.11022302462516E-16 |
| N0-vs-N1 |
6.817300E-03 |
|
|
